Glemser and AbbVie to Present at 4th Annual Pharma Labeling Compliance Conference

Ray Glemser, and John Polhemus of AbbVie will present the importance of global labeling for complying with IDMP at the 4th Annual Pharma Labeling Compliance Conference on March 16th in the following session:

Leveraging Global Labeling to Comply with the EMA’s Emerging IDMP Standard…

You may have heard that the European Medicines Agency and EU Health Authorities have stated their intention to receive all Identification of Medicinal Products (IDMP) in structured product labeling (SPL) format. The Food and Drug Administration also stated its intention to receive IDMP information in SPL format in the future. As a result of this intended convergence, a global labeling solution can play an increasingly important role in simplifying regulatory submissions in the US and EU in the next 5 years.

Glemser Technologies is excited to announce that our CEO, Ray Glemser, and John Polhemus of AbbVie will present the importance of global labeling for complying with IDMP at the 4th Annual Pharma Labeling Compliance Conference on March 16th in the following session:

Leveraging Global Labeling to Comply with the EMA’s Emerging IDMP Standard

  • Understanding the opportunity for US and EU regulatory submissions to be received in SPL and eCTD formats over the next five years
  • Planning to collect IDMP information consistently
  • Developing business insight from IDMP information
  • Identifying how structure content can help consolidate submissions
  • Understanding how a global labeling features can support IDMP compliance.